TrialInternational journal of hematology2018

Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.

Toshihiro Miyamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.